help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taylor, R. N.
Right arrow Articles by Milgrom, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taylor, R. N.
Right arrow Articles by Milgrom, E.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*RU-486
The Journal of Clinical Endocrinology & Metabolism Vol. 83, No. 11 4006-4012
Copyright © 1998 by The Endocrine Society


Original Studies

Promegestone (R5020) and Mifepristone (RU486) Both Function as Progestational Agonists of Human Glycodelin Gene Expression in Isolated Human Epithelial Cells1

Robert N. Taylor, Jean-François Savouret, Christian Vaisse, Jean-Louis Vigne, Isabelle Ryan, Daniela Hornung, Markku Seppälä and Edwin Milgrom

Unité de Recherches Hormones et Reproduction (R.N.T., J-F.S., C.V., E.M.), INSERM U135, Université Paris-Sud, Hôpital de Bicêtre APHP, 94275 Le Kremlin-Bicêtre, France; Reproductive Endocrinology Center (R.N.T., J-L.V., I.P., D.H.), University of California, San Francisco School of Medicine, San Francisco, California 94143; and Department of Obstetrics and Gynaecology (M.S.), Helsinki University Central Hospital, Haartmaninkatu 2, SF-00290 Helsinki, Finland

Address all correspondence and requests for reprints to: Robert N. Taylor, M.D., Ph.D., Reproductive Endocrinology Center, University of California, San Francisco School of Medicine, San Francisco, California 94143-0132.

One of the most abundant protein products of human secretory endometrium is glycodelin, a glycoprotein previously referred to as PP14. Although the precise function of this protein is unknown, its unique glycosylation pattern is believed to affect immunomodulatory activity during human embryonic implantation and inhibition of sperm-egg binding after ovulation. Having confirmed the expression of glycodelin in secretory endometrial glands, we used purified endometrial epithelial cell cultures to demonstrate the hormonal regulation of glycodelin synthesis and secretion. The findings were corroborated by transiently transfecting glycodelin gene promoter-reporter constructs into human epithelioid HeLa and Ishikawa cells. Our results indicate that glycodelin protein production by endometrial epithelial cells is directly up-regulated 4- to 9-fold by progestins and antiprogestins in vitro. Transcriptional regulation of the glycodelin gene promoter expressed in HeLa cells is progesterone receptor-dependent. As observed in the primary endometrial cells, progestins and antiprogestins both act as agonists on the in vitro expression of this endometrial gene. Our findings provide insight into the regulation of this abundant endometrial protein and raise interesting questions about the physical nature of the interaction of agonist- and antagonist-bound progesterone receptors with the glycodelin gene promoter.




This article has been cited by other articles:


Home page
Hum ReprodHome page
H. Uchida, T. Maruyama, K. Ohta, M. Ono, T. Arase, M. Kagami, H. Oda, T. Kajitani, H. Asada, and Y. Yoshimura
Histone deacetylase inhibitor-induced glycodelin enhances the initial step of implantation
Hum. Reprod., October 1, 2007; 22(10): 2615 - 2622.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. O. Burney, S. Talbi, A. E. Hamilton, K. C. Vo, M. Nyegaard, C. R. Nezhat, B. A. Lessey, and L. C. Giudice
Gene Expression Analysis of Endometrium Reveals Progesterone Resistance and Candidate Susceptibility Genes in Women with Endometriosis
Endocrinology, August 1, 2007; 148(8): 3814 - 3826.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
R. C Jaffe, S. D Ferguson-Gottschall, W. Gao, C. Beam, and A. T Fazleabas
Histone deacetylase inhibition and progesterone act synergistically to stimulate baboon glycodelin gene expression
J. Mol. Endocrinol., March 1, 2007; 38(3): 401 - 407.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
M. Wahab, A.H. Taylor, J.H. Pringle, J. Thompson, and F. Al-Azzawi
Trimegestone differentially modulates the expression of matrix metalloproteinases in the endometrial stromal cell
Mol. Hum. Reprod., March 1, 2006; 12(3): 157 - 167.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. D. Mueller, J.-L. Vigne, M. Streich, M. K. Tee, L. Raio, E. Dreher, N. A. Bersinger, and R. N. Taylor
2,3,7,8-Tetrachlorodibenzo-p-Dioxin Increases Glycodelin Gene and Protein Expression in Human Endometrium
J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4809 - 4815.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
R.D. Catalano, A. Yanaihara, A.L. Evans, D. Rocha, A. Prentice, S. Saidi, C.G. Print, D.S. Charnock-Jones, A.M. Sharkey, and S.K. Smith
The effect of RU486 on the gene expression profile in an endometrial explant model
Mol. Hum. Reprod., August 1, 2003; 9(8): 465 - 473.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
R.C. Jaffe, K.M. Donnelly, and A.T. Fazleabas
The induction of baboon glycodelin expression by progesterone is not through Sp1
Mol. Hum. Reprod., January 1, 2003; 9(1): 35 - 40.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
M. Seppala, R. N. Taylor, H. Koistinen, R. Koistinen, and E. Milgrom
Glycodelin: A Major Lipocalin Protein of the Reproductive Axis with Diverse Actions in Cell Recognition and Differentiation
Endocr. Rev., August 1, 2002; 23(4): 401 - 430.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-L. Vigne, D. Hornung, M. D. Mueller, and R. N. Taylor
Purification and Characterization of an Immunomodulatory Endometrial Protein, Glycodelin
J. Biol. Chem., May 11, 2001; 276(20): 17101 - 17105.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. D. Mueller, J.-L. Vigne, A. Minchenko, D. I. Lebovic, D. C. Leitman, and R. N. Taylor
Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors alpha and beta
PNAS, September 26, 2000; 97(20): 10972 - 10977.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1998 by The Endocrine Society